a Streptococcus dysgalactiue consists of at least five distinct subgroups on the basis of serogroups, biotypes, and hosts. A chemotaxonomic and phenotypic examination of 80 S. dysgalactiue strains representing the known diversity within this species and 49 reference strains representing all members of the streptococcal pyogenic species group revealed two subpopulations of strains within S. dysgalactiue. The name S. dysgulactiue subsp. dysgulactiue is proposed for strains of animal origin. These strains belong to Lancefield serogroups C and L, are alpha-, beta-, or nonhemolytic, and do not exhibit streptokinase activity on human plasminogen or proteolytic activity on human fibrin. The name S. dysgulactiue subsp. equisimilis is proposed for human isolates. These strains belong to Lancefield serogroups C and G, are beta-hemolytic, and exhibit streptokinase activity on human plasminogen and proteolytic activity on human fibrin.
ony-forming, beta-hemolytic strains which belong to S. dysgalactiae; (ii) the human, small-colony-forming, beta-hemolytic strains which belong to the "S. milleri" group; and (iii) the bovine, canine, and feline, beta-hemolytic strains, which belong to Streptococcus canis (6) . Finally, as explained above, the beta-hemolytic group L streptococci also belong to S. dysgalactiae (9) .
Although invalid, the name S. equisirnilis is still widely used (3, 7, 13) , and the nomenclature of the entire group remains confused. In order to shed light on the taxonomy of these organisms, we examined 80 S. dysgalactiae strains representing the various subgroups within this species and 49 additional reference strains by using whole-cell protein electrophoresis, a technique that has been shown to be very useful for differentiating strains at or below the species level (4) . The phenotypic characteristics of the clusters of strains obtained were extensively examined, and a new classification for these bacteria is proposed.
MATERIALS AND METHODS
Bacterial strains. Type and other rcfcrence strains were obtained from international culture collections as listed in Table 1 . The other strains examined were mostly our field isolates (isolates of L.A.D.). All of the strains used and their sources are listed in Table 1 . Bacteriological purity was checked by plating and examining living and Gram-stained cells.
Whole-cell protein analysis. All strains were grown for 24 h on brain heart infusion agar (catalog no. 0037-17-8; Difco Laboratories, Detroit, Mich.) incubated at 36 to 37°C in a microaerobic atmosphere containing approximately 5% O,,, 10% CO,, and 85% N,. Preparation of cellular protein extracts, polyacrylamide gel electrophoresis (PAGE), a dcnsitometric analysis, normalization and interpolation of the protein profiles, and a numerical analysis werc performed as described by Pot et al. (14) by using the GelCompar 3.1 software package (Applied Maths, Kortrijk, Belgium). The profiles were recorded and stored on a PC computer. The levels of similarity between pairs of traces were expressed by the Pearson product moment correlation coefficient convertcd for convenience to a percentage.
Physiological tests. Strains were grown on Columbia agar (Lab M, Paisley, United Kingdom) supplementcd with 5% cattle blood at 37°C in an atmosphere containing 5% CO, in air. Serological grouping with Lancefield group A, B, C, D, F, and G antigcns was carried out by using an Oxoid streptococcal grouping kit (Unipath, Basingstoke, United Kingdom). Acid (0.2 N HCl) Lancefield extracts of strains that did not react in these tests were tested by using group L antiserum obtained from D. G. Groothuis (National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands).
Streptokinase activity was determined on fibrin-plasma plates made up from ' Our isolate if not indicated otherwise.
Columbia blood agar base supplemented with 1 g of bovine fibrinogen fraction 1 (catalog no. F-8630; Sigma) per liter and 0.5% human plasma. Fibrinogen (100 mg) was first dissolved in 10 ml of phosphate-buffered saline and warmed for 10 min in a shaking water bath at 37°C. This preparation was then mixed with 100 ml of melted blood agar base and incubated for 10 min at 56°C to allow for precipitation of fibrin. Plates were poured immediately after plasma was added and were stored for a maximum of 3 days. A plate containing the same base and bovine fibrin without plasma was used as a control. In other tests, canine, porcine, equine, bovine, and avian (chicken) plasmas were used as plasminogen sources at the same concentration. A limited number of strains giving positive or negative results on Columbia agar supplemented with bovine fibrin and plasma were also tested on brain heart infusion agar (Oxoid, Basingstoke, United Kingdom) and on nutrient agar (Oxoid) similarly supplemented with human plasma and bovine fibrin. Strains were spot inoculated onto the plates, and clearing of bovine fibrin on plates containing plasma and not on plates containing only fibrin was considered evidence of activation of plasminogen to plasmin (streptokinase) activity. Reactions occurring on plasma-free as well as on plasma-supplemented plates were interpreted as evidence of fibrinolysis caused by protease activity. This activity was confirmed by tests on casein plates (Columbia agar supplemented with 0.5% skim milk) and gelatin plates (Columbia agar supplemented with 0.15% Bacto Gelatin [Difco]). Another test involved the use of Columbia agar made up from its separate components but with starch omitted (see below). Tests for protease activity on fibrin from other mammal species (humans, horses, and dogs) were also carried out. Fibrin plates prepared with fibrinogens from human plasma (catalog no. F-4129; fraction I, type 111; Sigma), from horse plasma (catalog no. F-9516; fraction I; Sigma), and from dog plasma (catalog no. F-7128; Sigma) as described above were used, but plasma was not added.
RESULTS
PAGE of whole-cell proteins. A total of 129 streptococci were examined. Duplicate protein extracts of several strains were prepared to check the reproducibility of the growth conditions and the preparation of the extracts. The level of correlation between duplicate protein patterns was at least 94% (data not shown). After visual comparison of the protein patterns with the dendrogram obtained after numerical comparison and clustering of the profiles, we identified 12 stable clusters above a similarity level of 84% (Fig. 1) . Cluster I comprised 45 S. dysgalactiae strains, including type strain LMG 16023, which clustered above a similarity level of 84.8%. These strains were isolated from various animals and belong to serogroups C and L ( Fig. 1; Table 1 ). Cluster I11 comprised 35 S. dysgalactiae strains that clustered above a similarity level of 84.7%. All of the cluster I11 strains were isolated from human sources and belong to serogroups C and G ( Fig. 1; Table 1 ). As shown in Fig. 1 , the reference strains of all of the other streptococcal species examined constituted homogeneous clusters, as follows: S. canis (cluster 11; grouping above a similarity level of 87.2%), Streptococcus pyogenes (cluster IV; grouping above a similarity level of 88.9%), Streptococcus uberis (cluster V; grouping above a similarity level of 84.1%), S. agalactiae (cluster VI; grouping above a similarity level of 85.8%), Streptococcus hyointestinalis (cluster VII; grouping above a similarity level of 91.7%), Streptococcus parauberis (cluster VIII; grouping above a similarity level of 96.3%), Streptococcus porcinus (cluster IX; grouping above a similarity level of 88.7%), Streptococcus anginosus (cluster X; grouping above a similarity level of 89.2%), and S. equi (cluster XI; grouping above a similarity level of 88.4%). Cluster XI1 comprised the two Streptococcus iniae reference strains and the type strain of Streptococcus shiloi, which grouped above a correlation level of 93.2%. Figure 2 shows the whole-cell protein patterns of representative strains belonging to different clusters.
Physiological tests. Physiological tests were performed on all 80 S. dysgalactiae strains. The serotypes of these strains according to the Lancefield scheme are shown in Table 1 . All of the strains except the bovine group C strains which were isolated from tonsils (strains LMG 14602, LMG 14604, and LMG 14605) and milk (strains LMG 15748, LMG 15749, LMG 16024, LMG 16025, and LMG 16023T [T = type strain]) and a single group C strain isolated from a pig (strain LMG 15744) exhibited beta-hemolysis on bovine blood agar. The bovine group C strains were alpha-hemolytic or nonhemolytic. Porcine strain LMG 15744 was also alpha-hemolytic.
All 35 strains belonging to cluster I11 as determined by the whole-cell protein analysis (Fig. 1) produced streptokinase activity on human plasminogen. This was shown by the presence of neat and easily visible zones of clearing surrounding streptococcal growth spots on bovine fibrin-plasma plates. Most reaction zones were visible after 1 day of incubation, but in a few cases, when growth was weak, they appeared only after 2 days. No strain reacted with plasminogens from the five animal species tested. The strains also did not cause fibrinolysis on bovine fibrin plates without plasma, and they were all negative in protease tests on milk agar and gelatin agar. The amylase reaction, which is visible with the naked eye on Columbia agar base without fibrin, did not interfere with the streptokinase tests because the starch contained in the medium was hydrolyzed and could not be demonstrated, even with iodine, following the addition of the fibrin preparations to the Columbia agar base. Tests performed with laboratory-prepared Columbia agar without starch gave the same results.
One equine protein electrophoretic cluster I strain (LMG 15824) produced some clearing on bovine fibrin-horse plasma plates. This clearing was visible beneath the growth spot only when the spot was washed off after 2 days of incubation. None of the 44 other cluster I strains tested, including the 4 other equine Lancefield group C strains, gave evidence of streptokinase activity in the plate tests. All of these strains except the eight bovine group C strains listed above were negative in tests performed on bovine fibrin plates with or without different types of plasma, including human plasma, and on milk agar and gelatin agar. These strains lacked streptokinase activity. However, the eight alpha-or nonhemolytic bovine group C strains (including the S. dysgalactiae type strain) produced ex- actly the same fibrinolysis zones on bovine fibrin plates with and without human or animal plasma. This indicates that the lysis observed was not due to plasmin activity resulting from the action of streptokinase on plasminogen, but was caused by proteolytic enzymes. Indeed, the same strains lysed casein on milk agar plates; however, they were not active on gelatin. All of the cluster 111 strains produced neat zones of fibrinolysis on human fibrin-containing plates without added plasma, animal isolates are shown ( Table 1 ). The molecular weight markers used (lane A) were (from left to right) lysozyme (molecular weight, 14,500), trypsin inhibitor (20,100), trypsinogen (24,000), carbonic anhydrase (29,000), glyceraldehyde-3-phosphate dehydrogenase (36,000), egg albumin (45,000), and bovine albumin (66,000).
while none of the cluster I strains exhibited any visible activity on this substrate. On canine fibrin plates, seven of the eight bovine cluster I strains produced wide zones of lysis which were identical to the zones that they produced on bovine fibrin agar plates and on milk agar plates. The remaining strains were not active on this type of fibrin. All of the strains studied were negative on horse fibrin.
DISCUSSION
Selection of S. dysguluctiue strains. S. dysgalactiae consists of at least five distinct subgroups on the basis of serogroups, biotypes, and hosts (5, 7). In the present study, the sources of the strains used included humans, horses, cows (and milk), pigs, dogs, chickens, and an iguana (Table 1) . These isolates represented nonhemolytic, alpha-hemolytic and beta-hemolytic S. dysgalactiae strains and serogroups C, G, and L. Thus, the strains used (Table 1 ) reflect the known diversity within this species.
Differentiation of streptococci by whole-cell protein electrophoresis. S. agalactiae, S. canis, S. dysgalactiae, S. equi, S. hyointestinalis, S. iniae, S. parauberis, S. porcinus, S. pyogenes, and S. uberis constitute the pyogenic species group as determined by 16s rRNA sequence analysis (1). Other streptococcal species are more remotely related to members of this group. In the present study, we included representative strains of all of these taxa as reference strains. In addition, S. anginosus was also included, as this species also comprises Lancefield group C and G strains. S. dysgalactiae strains were easily differentiated from other streptococci by whole-cell protein electrophoresis ( Fig. 1  and 2 ). However, these organisms fell into two major clusters, with all of the animal isolates constituting one cluster (cluster I) (Fig. 1) and the human isolates constituting the other (cluster 111) (Fig. 1) . Clusters I and I11 contain five (LMG 16023T through LMG 16025, LMG 16027, and LMG 16029) and one (LMG 16026T) reference strains, respectively, which were included in extensive DNA-DNA hybridization studies (9) ( Fig.  1 ; Table 1 ). The DNA-DNA binding values obtained by using the membrane filter technique between these strains and other S. dysgalactiae reference strains ranged from 66 to 100% (9), indicating that they form a homogeneous species. As determined by protein electrophoresis, these strains are representative of their respective clusters, and we therefore concluded that the two clusters indeed represent a genotypically coherent species despite salient protein electrophoretic differences. These differences occur mainly in the 45,000-to 55,000-molecularweight region (molecular weights were estimated roughly after comparison with the molecular weight ladder [Fig. 21 ). These two clusters apparently represent different electrophoretic types of S. dysgalactiae, and the origins of the S. dysgalactiae strains apparently are useful for identifying the electrophoretic subgroups. The collection of 80 strains examined in this study was selected in such a way that it represented the biochemical and serological diversity within the species, and we assume that it is therefore representative of the entire species. From an epidemiological point of view, these findings indicate that humans are never or only rarely infected by S. dysgalactiae strains from animals. Interestingly, the animals from which strains have been isolated are not only farm animals, but also companion animals. Consequently, not only farm workers but also pet owners are regularly exposed to S. dysgalactiae strains of animal origin, yet are not clinically infected. The improved method for distinguishing between animal-associated and humanassociated s. dysgalactiae strains described here should help trace possible zoonotic infections.
The reference strains of S. agalactiae, S. anginosus, S. canis, S. equi, S. iniae, S. hyointestinalis, S. parauberis, S. porcinus, S. pyogenes, and S. uberis constitute separate clusters on the dendrogram (Fig. 1) . The S, shiloi type strain forms a single cluster -, negative; +, positive; D, strain dependent.
with the S. iniae strains at a correlation level of 93.2%, confirming the reported synonymy of these two species (8) . As illustrated in Fig. 1 and 2 , S. equi subsp. equi and S. equi subsp. zooepidemicus cannot be differentiated by whole-cell protein electrophoresis. In contrast to the S. dysgalactiae strains, human and animal isolates of S. agalactiae, S. anginosus, and S. porcinus do not seem to exhibit significant differences in their whole-cell protein patterns (Table 1 ; Fig. 2 ). Phenotypic differentiation of S. dysgalactiae strains. Despite the superficial resemblance of the assay methods, direct proteolytic activity on human fibrin and streptokinase activity on human plasminogen are two different characteristics which can be used as easy ways to distinguish between human and animal isolates of S. dysgalactiae in diagnostic laboratories. McCoy and coworkers (13) found that streptokinases of different species obtained from different hosts were antigenically related. In their study, all of the group C strains tested, including strains referred to as S. equisimilis, S. equi subsp. equi, and S. equi subsp. zooepidemicus, had surface receptors that bound human, equine, and porcine plasmins. Human S. equisimilis strains were active only on human plasminogen, and this finding was confirmed and extended in the present study with avian, bovine, and canine plasmas. However, equine S. equisimilis strains and strains from the two S. equi subspecies activated horse plasma, while porcine S. equisimilis strains were active on porcine plasminogen and, very weakly, also on human plasminogen. In the study of McCoy et al. (13) , plasminogen activator activity was identified by hydrolysis of a plasmin-specific chromogenic substrate. This was detected in growth patches by a solid-phase assay. In our study, the enzyme was detected by lysis of fibrin, the normal substrate of plasmin. The difference in test results may be due to differences in the sensitivities of the two test systems.
Taxonomic status of S. dysgulactiae strains of human origin and animal origin. Species level identification of S. dysgulactiae strains is complex and provides little information for clinicians or epidemiologists. Beta-hemolytic group L S. dysgalactiae strains and alpha-hemolytic group C S. dysgalactiae strains colonize or infect only animals, whereas beta-hemolytic group G S. dysgalactiae strains colonize or infect only humans. Betahemolytic group C S. dysgalactiae strains occur in humans and animals, but the animal isolates do not occur in humans and vice versa. Clearly, from a practical point of view, S. dysguluctiue consists of two distinct subpopulations of strains, which produce very different whole-cell protein electrophoretic patterns, as demonstrated in Fig. 1 . The protein electrophoretic differences are comparable to the differences between distinct species in the group containing the pyogenic streptococci ( Fig.  1 and 2 ). In contrast, human and animal isolates of several other members of this species group do not differ significantly ( Fig. 1 and 2 ; Table 1 ). The two subpopulations of S. dysgalactiae can also be readily identified by phenotypic tests, as described above. In our opinion, these observations warrant distinct taxonomic status for each subpopulation of strains. As Farrow and Collins (9) demonstrated that both of the subpopulations belong to a single species, we propose that they should be classified as distinct subspecies of S. dysgalactiae. The name S. dysgalactiae subsp. dysgalactiae is used for the subpopulation of strains of animal origin because this subpopulation includes the type strain. Historically, the name S. equisimilis was given to human isolates resembling S. equi strains which occurred in animals, and therefore it is logical to use the name S. dysgalactiae subsp. equisimilis for the S. dysgaluctiae strains of human origin. In addition, this avoids creating more confusion by the introduction of a new name.
S. dysgalactiae subsp. dysgulactiae strains can be distinguished from S. dysgalactiae subsp. equisimilis strains by proteolysis of human fibrin, by the results of the human plasminogen-streptokinase test, by origin, and by whole-organism protein electrophoretic patterns. Lancefield serogrouping is also of value for differentiating the two subspecies; group L streptococci always belong to S. dysgalactiae subsp. dysgalactiae, while group G streptococci of human origin belong to S. dysgulactiae subsp. equisimilis (all animal group G strains described to date belong to S. cunis). These identifications can be confirmed by physiological tests (6,7). Also, for group C streptococci, origin can be used for presumptive identification; however, the strains should first be differentiated from S. equi and "S, milleri" (7, 9). Finally, Efstratiou et al. (7) described additional phenotypic tests that can be used to differentiate the two subspecies ( Table 2) .
Description of S. dysgulactiae subsp. dysgulactiae subsp. nov. The description of S. dysgalactiae subsp. dysgalactiae is the same as the description given by Farrow and Collins (9) for S. dysgalactiae, with following exceptions. Most strains are beta-hemolytic, but alpha-hemolytic and nonhemolytic strains occur, especially in bovine sources. Strains may react with Lancefield group C or L antigen but not with Lancefield group G antigen. Streptokinase activity on human plasminogen and proteolytic activity on human fibrin do not occur. The habitat is the respiratory and genital tracts of various animals, but apparently not humans.
Description of S. dysgalactiae subsp. equisimilis subsp. nov. The description of S. dysguluctiae subsp. equisimilis is the same as the description given by Farrow and Collins (9) for S. dysgalactiae, with following exceptions. Strains are beta-hemolytic and may react with Lancefield group C or G antigen but not with Lancefield group L antigen. Streptokinase activity occurs on human plasminogen, and proteolytic activity occurs on human fibrin. The habitat is the respiratory tracts and vaginas of humans. The type strain is LMG 16026 (= NCFB 1356), which belongs to Lancefield group G. 
